Cargando…
A Novel Homozygous Intronic Variant in TNNT2 Associates With Feline Cardiomyopathy
BACKGROUND: Hypertrophic cardiomyopathy (HCM) is a genetic disease of the heart and the most common cause of sudden cardiac death in the young. HCM is considered a disease of the sarcomere owing to the large number of mutations in genes encoding sarcomeric proteins. The riddle lies in discovering ho...
Autores principales: | McNamara, James W., Schuckman, Maggie, Becker, Richard C., Sadayappan, Sakthivel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7701303/ https://www.ncbi.nlm.nih.gov/pubmed/33304277 http://dx.doi.org/10.3389/fphys.2020.608473 |
Ejemplares similares
-
Genotype-Driven Pathogenesis of Atrial Fibrillation in Hypertrophic Cardiomyopathy: The Case of Different TNNT2 Mutations
por: Pioner, Josè Manuel, et al.
Publicado: (2022) -
Mutations in myosin S2 alter cardiac myosin-binding protein-C interaction in hypertrophic cardiomyopathy in a phosphorylation-dependent manner
por: Singh, Rohit R., et al.
Publicado: (2021) -
Recent Advances in the Molecular Genetics of Familial Hypertrophic Cardiomyopathy in South Asian Descendants
por: Kraker, Jessica, et al.
Publicado: (2016) -
Mechanisms of Arrhythmogenicity of Hypertrophic Cardiomyopathy-Associated Troponin T (TNNT2) Variant I79N
por: Shafaattalab, Sanam, et al.
Publicado: (2021) -
Hypertrophic cardiomyopathy clinical phenotype is independent of gene mutation and mutation dosage
por: Viswanathan, Shiv Kumar, et al.
Publicado: (2017)